|
18 Jan 2008 |
Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
|
|
11 Jan 2008 |
Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
|
|
08 Jan 2008 |
Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization
|
|
08 Jan 2008 |
Tacere Therapeutics Eenters Collaborationa and License Agreement With Pfizer to Develop and Commercilize RNAi Hepatitis C Drug
|
|
07 Jan 2008 |
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
|
|
27 Dec 2007 |
Leiden University Medical Center and Prosensa B.V. Announce New England Journal of Medicine Publication of First Successful Clinical Study with RNA-based Therapeutic PRO051 in Duchenne Muscular Dystrophy
|
|
20 Dec 2007 |
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
|
|
18 Dec 2007 |
Year-end clinical trial update
|
|
18 Dec 2007 |
Epeius Biotechnologies gains commercial approval for Rexin-G(R), a tumor-targeted gene-based medicine for metastatic cancer
|
|
13 Dec 2007 |
Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection
|
|
13 Dec 2007 |
Oxford biomedica initiates Phase I/II trial of prosavin (R) gene-based treatment for parkinson's disease
|
|
12 Dec 2007 |
Gene A/S begins Phase Ib clinical trial with NsG0202 for the treatment of Alzheimer's disease
|
|
12 Dec 2007 |
Ceregene Presents Long-Term Follow-Up from Phase 1 Trial of CERE-120 in Parkinson's Disease
|
|
12 Dec 2007 |
NeuroSearch's associated company NsGene A/S starts Phase Ib clinical study with NsG0202 for the treatment of Alzheimer's disease
|
|
10 Dec 2007 |
Sangamo BioSciences Announces Presentation of Data for ZFP Therapeutic for Glioblastoma at American Society for Hematology Meeting
|
|
10 Dec 2007 |
Osiris Therapeutics Reports Positive Results for Prochymal(TM) as
|
|
05 Dec 2007 |
Senesco Technologies Initiates Preclinical Studies for Cancer Target
|
|
04 Dec 2007 |
Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
|
|
03 Dec 2007 |
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
|
|
28 Nov 2007 |
Geron initiates clinical trial of telomerase inhibitor drug in patients with multiple myeloma
|
|
27 Nov 2007 |
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
|
|
27 Nov 2007 |
Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis
|
|
27 Nov 2007 |
Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
|
|
26 Nov 2007 |
Targeted Genetics Announces That FDA Has Removed Hold on Phase I/II Clinical Trial of tgAAC94 for Inflammatory Arthritis
|
|
20 Nov 2007 |
Covalon Achieves Important Milestone in Its Cell-Based Gene Therapy for Treating Congestive Heart Failure and Tissue Regeneration
|
